Global 3D Printing for Aerospace & Defence Market Research 2011- 2022

  • The global 3D Printing for Aerospace & Defence market is estimated to reach 1.3 Billion USD in 2017. The objective of report is to define, segment, and project the market on the basis of print materials, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
    Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
    By Print Materials
    Plastic Material
    Ceramics Matrial
    Metals Material
    By Technology
    SLA
    FDM
    DMLS
    SLM
    SLS
    EBM
    Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
    Europe
    North America
    China
    Japan & Korea
    Based on Application, the report describes major Application share of regional market. Application mentioned as follows:
    Aerospace
    Defense
    Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
    Stratasys
    3D Systems
    Arcam Group
    Renishaw
    ExOne
    Optomec
    SLM Solutions
    EnvisionTEC
    VoxelJet AG
    Sciaky Inc
    EOS e-Manufacturing Solutions

  • 1 Market Overview
    1.1 Objectives of Research
    1.1.1 Definition
    1.1.2 Specifications
    1.2 Market Segment
    1.2.1 by Type
    1.2.1.1 TNF
    1.2.1.2 IL
    1.2.1.3 IFN
    1.2.1.4 EGF
    1.2.2 by Application
    1.2.2.1 Cancer & Malignancy
    1.2.2.2 Arthritis
    1.2.2.3 Asthma & Airway Inflammation
    1.2.3 by Regions
    2 Industry Chain
    2.1 Industry Chain Structure
    2.2 Upstream
    2.3 Market
    2.3.1 SWOT
    2.3.2 Dynamics
    3 Environmental Analysis
    3.1 Policy
    3.2 Economic
    3.3 Technology
    3.4 Market Entry
    4 Market Segmentation by Type
    4.1 Market Size
    4.1.1 Global TNF Market, 2011-2016
    4.1.2 Global IL Market, 2011-2016
    4.1.3 Global IFN Market, 2011-2016
    4.1.4 Global EGF Market, 2011-2016
    4.2 Market Forecast
    4.2.1 Global TNF Market Forecast, 2017-2022
    4.2.2 Global IL Market Forecast, 2017-2022
    4.2.3 Global IFN Market Forecast, 2017-2022
    4.2.4 Global EGF Market Forecast, 2017-2022
    5 Market Segmentation by Application
    5.1 Market Size
    5.1.1 Global Cancer & Malignancy Market, 2011-2016
    5.1.2 Global Arthritis Market, 2011-2016
    5.1.3 Global Asthma & Airway Inflammation Market, 2011-2016
    5.2 Market Forecast
    5.2.1 Global Cancer & Malignancy Market Forecast, 2017-2022
    5.2.2 Global Arthritis Market Forecast, 2017-2022
    5.2.3 Global Asthma & Airway Inflammation Market Forecast, 2017-2022
    6 Market Segmentation by Region
    6.1 Market by Region
    6.1.1 Europe
    6.1.1.1 Europe Cytokines Market, 2011-2016
    6.1.1.2 Europe Cytokines Market by Type
    6.1.1.3 Europe Cytokines Market by Application
    6.2.1 North America
    6.1.2.1 North America Cytokines Market, 2011-2016
    6.1.2.2 North America Cytokines Market by Type
    6.1.2.3 North America Cytokines Market by Application
    6.3.1 China
    6.1.3.1 China Cytokines Market, 2011-2016
    6.1.3.2 China Cytokines Market by Type
    6.1.3.3 China Cytokines Market by Application
    6.4.1 Japan & Korea
    6.1.4.1 Japan & Korea Cytokines Market, 2011-2016
    6.1.4.2 Japan & Korea Cytokines Market by Type
    6.1.4.3 Japan & Korea Cytokines Market by Application
    6.2 Market Forecast
    6.2.1 Global Europe Market Forecast, 2017-2022
    6.2.2 Global North America Market Forecast, 2017-2022
    6.2.3 Global China Market Forecast, 2017-2022
    6.2.4 Global Japan & Korea Market Forecast, 2017-2022
    7 Market Competitive
    7.1 Global Cytokines Market by Vendors
    7.2 Market Concentration
    7.3 Price & Factors
    7.4 Marketing Channel
    8 Major Vendors
    8.1 AbbVie
    8.1.1 Profile
    8.1.2 Business Performance
    8.2 Johnson & Johnson
    8.2.1 Profile
    8.2.2 Business Performance
    8.3 GlaxoSmithKline
    8.3.1 Profile
    8.3.2 Business Performance
    8.4 Novartis
    8.4.1 Profile
    8.4.2 Business Performance
    8.5 Roche
    8.5.1 Profile
    8.5.2 Business Performance
    8.6 Pfizer
    8.6.1 Profile
    8.6.2 Business Performance
    8.7 Sanofi
    8.7.1 Profile
    8.7.2 Business Performance
    8.8 Bayer HealthCare Pharmaceuticals
    8.8.1 Profile
    8.8.2 Business Performance
    8.9 Thermo Fisher Scientific
    8.9.1 Profile
    8.9.2 Business Performance
    8.10 Biocon
    8.10.1 Profile
    8.10.2 Business Performance
    8.11 Biotechne
    9 Conclusion

  • Your Name (required)

    Your Email (required)

    Telephone Number (required)

    Name of Company (required)

    Designation (required)

    Country Name (required)

    How can we help you?

    Prove You are Human (required)

    captcha
    Enter Capcha Image Properly

  • Your Name (required)

    Your Email (required)

    Telephone Number (required)

    Name of Company (required)

    Designation (required)

    Country Name (required)

    How can we help you?

    Prove You are Human (required)

    captcha
    Enter Capcha Image Properly